Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 22544195.
- Also identified by DOI 10.1093/cid/cir988 and PMC identifier 3338307.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26,448 individuals were on treatment. With rapid scale-up of ART, some degree of human immunodeficiency virus transmitted drug resistance (TDR) is inevitable. Following World Health Organization methods, between June 2008 and July 2009, Burkina Faso assessed TDR in primigravid pregnant women aged <25 years attending antenatal care clinics in Ouagadougou, Burkina Faso. TDR was classified as moderate (5%-15%) for both nucleoside reverse-transcriptase inhibitors and nonnucleoside reverse-transcriptase inhibitors. The observed moderate TDR in Ouagadougou is a cause for concern and calls for closer monitoring of Burkina Faso's ART program.
Medical subject headings
- Anti-Retroviral Agents
- HIV
- HIV Infections
- Pregnancy Complications, Infectious